Cargando…
Changes Over Time in Glycemic Control, Insulin Sensitivity, and β-Cell Function in Response to Low-Dose Metformin and Thiazolidinedione Combination Therapy in Patients With Impaired Glucose Tolerance
OBJECTIVE: In the Canadian Normoglycemia Outcome Evaluation (CANOE) trial, low-dose rosiglitazone/metformin reduced the risk of diabetes in subjects with impaired glucose tolerance by 66% over a median of 3.9 years. We evaluate the temporal changes in glycemic control, insulin sensitivity, and β-cel...
Autores principales: | Retnakaran, Ravi, Qi, Ying, Harris, Stewart B., Hanley, Anthony J., Zinman, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120173/ https://www.ncbi.nlm.nih.gov/pubmed/21709296 http://dx.doi.org/10.2337/dc11-0046 |
Ejemplares similares
-
Isolated Hyperglycemia at 1 Hour on Oral Glucose Tolerance Test in Pregnancy Resembles Gestational Diabetes Mellitus in Predicting Postpartum Metabolic Dysfunction
por: Retnakaran, Ravi, et al.
Publicado: (2008) -
Hepatic fat and glucose tolerance in women with recent gestational diabetes
por: Mehmood, Sadia, et al.
Publicado: (2018) -
Hepatic Insulin Resistance Is an Early Determinant of Declining β-Cell Function in the First Year Postpartum After Glucose Intolerance in Pregnancy
por: Retnakaran, Ravi, et al.
Publicado: (2011) -
Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes
por: Kramer, Caroline K, et al.
Publicado: (2016) -
Determinants of longitudinal change in insulin clearance: the Prospective Metabolism and Islet Cell Evaluation cohort
por: Semnani-Azad, Zhila, et al.
Publicado: (2019)